Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer.
Supiot S, Vaugier L, Pasquier D, Buthaud X, Magné N, Peiffert D, Sargos P, Crehange G, Pommier P, Loos G, Hasbini A, Latorzeff I, Silva M, Denis F, Lagrange JL, Morvan C, Campion L, Blanc-Lapierre A. Supiot S, et al. Among authors: crehange g. Eur Urol. 2021 Oct;80(4):405-414. doi: 10.1016/j.eururo.2021.06.010. Epub 2021 Jul 8. Eur Urol. 2021. PMID: 34247896 Clinical Trial.
Early choline levels from 3-tesla MR spectroscopy after exclusive radiation therapy in patients with clinically localized prostate cancer are predictive of plasmatic levels of PSA at 1 year.
Crehange G, Maingon P, Gauthier M, Parfait S, Cochet A, Mirjolet C, Bonnetain F, Cormier L, Brunotte F, Walker P. Crehange G, et al. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e407-13. doi: 10.1016/j.ijrobp.2011.03.008. Epub 2011 May 24. Int J Radiat Oncol Biol Phys. 2011. PMID: 21605949
Focal HIFU for prostate cancer.
Créhange G, Azria D, Lartigau E, Peiffert D, Maingon P. Créhange G, et al. Lancet Oncol. 2012 Jul;13(7):e282-3; author reply e284. doi: 10.1016/S1470-2045(12)70244-9. Epub 2012 Jun 28. Lancet Oncol. 2012. PMID: 22748265 No abstract available.
[Prospective economic evaluation of image-guided radiation therapy for prostate cancer in the framework of the national programme for innovative and costly therapies assessment].
Pommier P, Morelle M, Perrier L, de Crevoisier R, Laplanche A, Dudouet P, Mahé MA, Chauvet B, Nguyen TD, Créhange G, Zawadi A, Chapet O, Latorzeff I, Bossi A, Beckendorf V, Touboul E, Muracciole X, Bachaud JM, Supiot S, Lagrange JL. Pommier P, et al. Among authors: crehange g. Cancer Radiother. 2012 Sep;16(5-6):444-51. doi: 10.1016/j.canrad.2012.07.178. Epub 2012 Aug 27. Cancer Radiother. 2012. PMID: 22951488 Clinical Trial. French.
Cost of prostate image-guided radiation therapy: results of a randomized trial.
Perrier L, Morelle M, Pommier P, Lagrange JL, Laplanche A, Dudouet P, Supiot S, Chauvet B, Nguyen TD, Crehange G, Beckendorf V, Pene F, Muracciole X, Bachaud JM, Le Prisé E, de Crevoisier R. Perrier L, et al. Among authors: crehange g. Radiother Oncol. 2013 Jan;106(1):50-8. doi: 10.1016/j.radonc.2012.11.011. Epub 2013 Jan 17. Radiother Oncol. 2013. PMID: 23333022 Free article. Clinical Trial.
[Hypofractionated radiotherapy in prostate cancer].
Supiot S, Créhange G, Latorzeff I, Pommier P, Paumier A, Rio E, Delaroche G, Guérif S, Catton C, Martin J, Lisbona A. Supiot S, et al. Among authors: crehange g. Cancer Radiother. 2013 Oct;17(5-6):349-54. doi: 10.1016/j.canrad.2013.05.005. Epub 2013 Aug 20. Cancer Radiother. 2013. PMID: 23973460 Review. French.
[Preoperative radiotherapy for rectal cancer: target volumes].
Huertas A, Marchal F, Peiffert D, Créhange G. Huertas A, et al. Among authors: crehange g. Cancer Radiother. 2013 Oct;17(5-6):477-85. doi: 10.1016/j.canrad.2013.06.041. Epub 2013 Sep 5. Cancer Radiother. 2013. PMID: 24011671 French.
225 results